Lewy bodies are not increased in progressive supranuclear palsy compared with normal controls

Neurology

Volumn 57, Issue 9, 2001, Pages 1675-1678

  Tsuboi, Y ^a   Ahlskog, J E ^c   Apaydin, H ^b   Parisi, J E ^c   Dickson, Dennis W ^a  

^a MAYO CLINIC   (United States)

^b ISTANBUL UNIVERSITY   (Turkey)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; TAU PROTEIN;

ADULT; AGED; AMYGDALOID NUCLEUS; ARTICLE; CONTROLLED STUDY; FEMALE; FOREBRAIN; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEWY BODY; MAJOR CLINICAL STUDY; MALE; NEURITE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SUBSTANTIA NIGRA;

EID: 0035856450     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.57.9.1675     Document Type: Article

References (27)

1. Lewy bodies in Alzheimer's disease: A neuropathological review of 145 cases using alpha-synuclein immunohistochemistry
2. Numerous and widespread alpha-synuclein-negative Lewy bodies in an asymptomatic patient
3. Incidental occurrence of Lewy bodies in the brains of elderly patients - The relevance to aging and Parkinson's disease
4. Concentric hyalin intraneuronal inclusions of Lewy type in the brain of elderly persons (50 incidental cases). Relationship to parkinsonism
5. The pathology of parkinsonism
6. Cytoplasmic inclusion in ganglion cells associated with parkinsonian states
7. Concentric hyaline inclusion body formation in mental disease. Analysis of twenty-seven cases
8. Idiopathic Parkinson's disease and the Lewy body disorders
9. Progressive supranuclear palsy: A heterogenous degeneration involving the brainstem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia, and dementia
10. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop
11. Significant association between the tau gene A0/A0 genotype and Parkinson's disease
12. Genetic evidence for the involvement of τ in progressive supranuclear palsy
13. Neuropathological stageing of Alzheimer-related changes
14. Pathological markers associated with normal aging and dementia in the elderly
15. Distinctive neuropathology revealed by α-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p
16. Autopsy findings in parkinsonism following treatment with levodopa
17. Progressive supranuclear palsy
18. An atypical case of progressive supranuclear palsy
19. Progressive supranuclear palsy with Lewy bodies
20. A case of Down's syndrome with diffuse Lewy body disease and Alzheimer's disease
21. Familial Alzheimer's disease and cortical Lewy bodies: Is there a genetic susceptibility factor?
22. Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease
23. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes
24. Evidence for oxidative stress in the subthalamic nucleus in progressive supranuclear palsy
25. Frontal lobe dysfunction in progressive supranuclear palsy: Evidence for oxidative stress and mitochondrial impairment
26. Alpha-synuclein promotes mitochondrial deficit and oxidative stress
27. Role of oxidative changes in the degeneration of dopamine terminals after injection of neurotoxic levels of dopamine